Buy CytomX Therapeutics Stock | CTMX Stock Price & Latest News | Public
CTMX

CytomX Therapeutics

$0.00 (0.00%)Today

    About CTMX

    CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multipl...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.26
    0.01
    -0.25
    -0.5
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.50

    Actual EPS
    Q4 2020

    Stats

    Market Cap$338,36M
    Volume7,35k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.44
    1 Year Low$3.60
    Open$7.38
    High$7.50
    Low$7.30

    Buy any stock with any amount of money.

    Download the App
    Download the app